5
Views
23
CrossRef citations to date
0
Altmetric
Original Article

Long-Term Treatment of Patients with Endocrine Gastrointestinal Tumours with the Somatostatin Analogue SMS 201-995

, , , &
Pages 230-237 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

W. Creutzfeldt, H. H. Bartsch, U. Jacubaschke & F. Stöckmann. (1991) Treatment of Gastrointestinal Endocrine Tumours with Interferon-α and Octreotide. Acta Oncologica 30:4, pages 529-535.
Read now
A. I. Vinik, N. Thompson, F. Eckhauser & A. R. Moattari. (1989) Clinical Features of Carcinoid Syndrome and the Use of Somatostatin Analogue in Its Management. Acta Oncologica 28:3, pages 389-402.
Read now
K. Witt & N. Thorsgaard Pedersen. (1989) The Long-Acting Somatostatin Analogue SMS 201-995 Causes Malabsorption. Scandinavian Journal of Gastroenterology 24:10, pages 1248-1252.
Read now
J. M. Conlon, C. F. Deacon, G. Richter, F. Stöckmann & W. Creutzfeldt. (1987) Circulating Tachykinins (Substance P, Neurokinin A, Neuropeptide K) and the Carcinoid Flush. Scandinavian Journal of Gastroenterology 22:1, pages 97-105.
Read now

Articles from other publishers (19)

Justin Geoghegan & Theodore N. Pappas. (1997) Clinical Uses of Gut Peptides. Annals of Surgery 225:2, pages 145-154.
Crossref
A. Lamrani, N. Vidon, P. Sogni, P. Nepveux, F. Catus, J. Blumberg & S. Chaussade. (2008) Effects of lanreotide, a somatostatin analogue, on postprandial gastric functions and biliopancreatic secretions in humans. British Journal of Clinical Pharmacology 43:1, pages 65-70.
Crossref
A. Lamrani, N. Vidon, P. Sogni, P. Nepveux, F. Catus, J. Blumberg & S. Chaussade. (1997) Effects of lanreotide, a somatostatin analogue, on postprandial gastric functions and biliopancreatic secretions in humans. British Journal of Clinical Pharmacology 43:1, pages 65-70.
Crossref
Ch Schöber, E Schmoll, H.-J Schmoll, H Poliwoda, F Schuppert, M Stahl, C Bokemeyer, H Wilke & J Weiss. (1992) Antitumour effect and symptomatic control with interferon α2b in patients with endocrine active tumours. European Journal of Cancer 28:10, pages 1664-1666.
Crossref
Roger D. Hurst & Irvin M. Modlin. (1991) The therapeutic role of octreotide in the management of surgical disorders. The American Journal of Surgery 162:5, pages 499-507.
Crossref
B.Mark Evers, Courtney M. TownsendJr.Jr., J.Robert Upp, Erick Allen, Stephen C. Hurlbut, Sun Whe Kim, Srinivasan Rajaraman, Pomila Singh, Jean Claude Reubi & James C. Thompson. (1991) Establishment and characterization of a human carcinoid in nude mice and effect of various agents on tumor growth. Gastroenterology 101:2, pages 303-311.
Crossref
Michael S. Hickey. (1991) Nutritional Support of Patients with AIDS. Surgical Clinics of North America 71:3, pages 645-664.
Crossref
E. Kornely, R. Schlaghecke & F. A. Horster. (1991) Palliative therapy of an ectopic cushing's syndrome due to a metastatic carcinoid tumor. Klinische Wochenschrift 69:4, pages 173-176.
Crossref
Nancy Brown, Philip E. Johnston, Patricia Arns, Renata Bluhm & Robert A. Branch. (1990) Octreotide: A Long-Acting Somatostatin Analog. The American Journal of the Medical Sciences 300:4, pages 267-273.
Crossref
C. Schöber, F. Schuppert, M. Stahl, H. Köhne-Wömpner, H. Wilke, H.-J. Schmoll & H. Poliwoda. 1990. Cytokines in Hemopoiesis, Oncology, and AIDS. Cytokines in Hemopoiesis, Oncology, and AIDS 615 624 .
Paul N. Maton. (1989) The Use of the Long-Acting Somatostatin Analogue, Octreotide Acetate, in Patients with Islet Cell Tumors. Gastroenterology Clinics of North America 18:4, pages 897-922.
Crossref
Aaron I. Vinik, Michael K. McLeod, Lorraine M. Fig, Brahm Shapiro, Ricardo V. Lloyd & Kyung Cho. (1989) Clinical Features, Diagnosis, and Localization of Carcinoid Tumors and Their Management. Gastroenterology Clinics of North America 18:4, pages 865-896.
Crossref
Paul N. Maton, Jerry D. Gardner & Robert T. Jensen. (1989) Use of long-acting somatostatin analog SMS 201-995 in patients with pancreatic islet cell tumors. Digestive Diseases and Sciences 34:S3, pages S28-S39.
Crossref
Aaron Vinik & Ali Reza Moattari. (1989) Use of somatostatin analog in management of carcinoid syndrome. Digestive Diseases and Sciences 34:S3, pages S14-S27.
Crossref
H. J. Balks, J. M. Conlon, W. Creutzfeldt & F. Stöckmann. (1989) Effect of a long-acting somatostatin analogue (octreotide) on circulating tachykinins and the pentagastrin-induced carcinoid flush. European Journal of Clinical Pharmacology 36:2, pages 133-137.
Crossref
Avrum Z. Bluming & Ronald R. Berez. (1988) Successful treatment of unstable angina in malignant carcinoid syndrome using the long-acting somatostatin analogue SMS 201-995 (Sandostatin). The American Journal of Medicine 85:6, pages 872-874.
Crossref
J. Kunert-Radek, H. Stepien, A. Radek & M. Pawlikowski. (1987) Somatostatin suppression of meningioma cell proliferation in vitro . Acta Neurologica Scandinavica 75:6, pages 434-436.
Crossref
Werner Creutzfeldt, Bernhard Lembcke, Ulrich R. Folsch, Sebastian Schleser & Irmtraut Koop. (1987) Effect of somatostatin analogue (SMS 201-995, sandostatin) on pancreatic secretion in humans. The American Journal of Medicine 82:5, pages 49-54.
Crossref
Werner Creutzfeldt & Fritz Stöckmann. (1987) Carcinoids and carcinoid syndrome. The American Journal of Medicine 82:5, pages 4-16.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.